Peugeot Invest SA (PEUG)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 52.00 |
|---|---|
| 52-week range | 48.80 – 79.00 |
| Return, 1 month / 3 months | +3.0% / −5.8% |
| Return, 1 year / 3 years | −28.1% / −37.3% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 23.7% |
| Worst drawdown (1 year) | -32.7% |
| Average daily value traded | 0.39M EUR |
| Dividend yield | 6.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Peugeot Invest is an investment holding company controlled by the Peugeot family and based in Paris. It manages a portfolio of long-term stakes in industrial and financial businesses, including automotive and aerospace suppliers, through which it takes minority positions and supports their development. Its shareholders are the family and outside investors, and it also makes direct investments in unquoted companies alongside its holdings in public firms. The company operates as a patient investor rather than an operating business.
The shares are listed on the Euronext Paris in France under the code PEUG, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Peugeot Invest SA (PEUG) trades on the Euronext Paris in France. It last closed at EUR 52.00 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 285 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 28.1% and over the last three months it fell 5.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.0% | ||
| From 52-week high | -34.2% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.8% | ||
| 6-month return | -15.4% | ||
| 12-month return, skipping the last month | -30.1% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 23.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.7% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 0.39M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | +3.0% |
| 3 months | −5.8% |
| 6 months | −15.4% |
| 1 year | −28.1% |
| 3 years | −37.3% |
| 5 years | −48.4% |
Signals
| 50-day / 200-day average | 54.01 / 59.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 May 2026 | EUR 3.2500 |
| 23 May 2025 | EUR 3.2500 |
| 29 May 2024 | EUR 3.2500 |
| 18 May 2023 | EUR 2.8500 |
| 18 May 2022 | EUR 2.6500 |
| 17 May 2021 | EUR 2.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.